Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Evidence of Tau Hyperphosphorylation and Dystrophic Microglia in the Common Marmoset.

Rodriguez-Callejas JD, Fuchs E, Perez-Cruz C.

Front Aging Neurosci. 2016 Dec 22;8:315. doi: 10.3389/fnagi.2016.00315. eCollection 2016. Erratum in: Front Aging Neurosci. 2017 Feb 21;9:32.

2.

Patterns of Cortical and Subcortical Amyloid Burden across Stages of Preclinical Alzheimer's Disease.

Edmonds EC, Bangen KJ, Delano-Wood L, Nation DA, Furst AJ, Salmon DP, Bondi MW; Alzheimer’s Disease Neuroimaging Initiative.

J Int Neuropsychol Soc. 2016 Nov;22(10):978-990.

3.

High-speed atomic force microscopy reveals structural dynamics of amyloid β1-42 aggregates.

Watanabe-Nakayama T, Ono K, Itami M, Takahashi R, Teplow DB, Yamada M.

Proc Natl Acad Sci U S A. 2016 May 24;113(21):5835-40. doi: 10.1073/pnas.1524807113. Epub 2016 May 9.

4.

Regional brain hypometabolism is unrelated to regional amyloid plaque burden.

Altmann A, Ng B, Landau SM, Jagust WJ, Greicius MD; Alzheimer’s Disease Neuroimaging Initiative.

Brain. 2015 Dec;138(Pt 12):3734-46. doi: 10.1093/brain/awv278. Epub 2015 Sep 29.

5.

Cellular Models of Aggregation-dependent Template-directed Proteolysis to Characterize Tau Aggregation Inhibitors for Treatment of Alzheimer Disease.

Harrington CR, Storey JM, Clunas S, Harrington KA, Horsley D, Ishaq A, Kemp SJ, Larch CP, Marshall C, Nicoll SL, Rickard JE, Simpson M, Sinclair JP, Storey LJ, Wischik CM.

J Biol Chem. 2015 Apr 24;290(17):10862-75. doi: 10.1074/jbc.M114.616029. Epub 2015 Mar 10.

6.

The Cerebrovascular Basement Membrane: Role in the Clearance of β-amyloid and Cerebral Amyloid Angiopathy.

Morris AW, Carare RO, Schreiber S, Hawkes CA.

Front Aging Neurosci. 2014 Sep 19;6:251. doi: 10.3389/fnagi.2014.00251. eCollection 2014. Review.

7.

At the interface of sensory and motor dysfunctions and Alzheimer's disease.

Albers MW, Gilmore GC, Kaye J, Murphy C, Wingfield A, Bennett DA, Boxer AL, Buchman AS, Cruickshanks KJ, Devanand DP, Duffy CJ, Gall CM, Gates GA, Granholm AC, Hensch T, Holtzer R, Hyman BT, Lin FR, McKee AC, Morris JC, Petersen RC, Silbert LC, Struble RG, Trojanowski JQ, Verghese J, Wilson DA, Xu S, Zhang LI.

Alzheimers Dement. 2015 Jan;11(1):70-98. doi: 10.1016/j.jalz.2014.04.514. Epub 2014 Jul 9. Review.

8.

Perforant path synaptic loss correlates with cognitive impairment and Alzheimer's disease in the oldest-old.

Robinson JL, Molina-Porcel L, Corrada MM, Raible K, Lee EB, Lee VM, Kawas CH, Trojanowski JQ.

Brain. 2014 Sep;137(Pt 9):2578-87. doi: 10.1093/brain/awu190. Epub 2014 Jul 9.

9.

Foreign language training as cognitive therapy for age-related cognitive decline: a hypothesis for future research.

Antoniou M, Gunasekera GM, Wong PC.

Neurosci Biobehav Rev. 2013 Dec;37(10 Pt 2):2689-98. doi: 10.1016/j.neubiorev.2013.09.004. Epub 2013 Sep 16. Review.

10.

Molecular structure of β-amyloid fibrils in Alzheimer's disease brain tissue.

Lu JX, Qiang W, Yau WM, Schwieters CD, Meredith SC, Tycko R.

Cell. 2013 Sep 12;154(6):1257-68. doi: 10.1016/j.cell.2013.08.035.

11.

Dual immunofluorescence study of citrullinated proteins in Alzheimer diseased frontal cortex.

Nicholas AP.

Neurosci Lett. 2013 Jun 17;545:107-11. doi: 10.1016/j.neulet.2013.04.028. Epub 2013 May 3.

12.

Synapse stability in the precuneus early in the progression of Alzheimer's disease.

Scheff SW, Price DA, Schmitt FA, Roberts KN, Ikonomovic MD, Mufson EJ.

J Alzheimers Dis. 2013;35(3):599-609. doi: 10.3233/JAD-122353.

13.

Aging, synaptic dysfunction, and insulin-like growth factor (IGF)-1.

Deak F, Sonntag WE.

J Gerontol A Biol Sci Med Sci. 2012 Jun;67(6):611-25. doi: 10.1093/gerona/gls118. Epub 2012 Apr 12. Review.

14.

Patterns of striatal degeneration in frontotemporal dementia.

Halabi C, Halabi A, Dean DL, Wang PN, Boxer AL, Trojanowski JQ, Dearmond SJ, Miller BL, Kramer JH, Seeley WW.

Alzheimer Dis Assoc Disord. 2013 Jan-Mar;27(1):74-83. doi: 10.1097/WAD.0b013e31824a7df4.

15.

Submicromolar Aβ42 reduces hippocampal glutamate receptors and presynaptic markers in an aggregation-dependent manner.

Wisniewski ML, Hwang J, Bahr BA.

Biochim Biophys Acta. 2011 Dec;1812(12):1664-74. doi: 10.1016/j.bbadis.2011.09.011. Epub 2011 Sep 25.

16.

Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies.

Nelson PT, Head E, Schmitt FA, Davis PR, Neltner JH, Jicha GA, Abner EL, Smith CD, Van Eldik LJ, Kryscio RJ, Scheff SW.

Acta Neuropathol. 2011 May;121(5):571-87. doi: 10.1007/s00401-011-0826-y. Epub 2011 Apr 24. Review.

17.

Increased brain iron coincides with early plaque formation in a mouse model of Alzheimer's disease.

Leskovjan AC, Kretlow A, Lanzirotti A, Barrea R, Vogt S, Miller LM.

Neuroimage. 2011 Mar 1;55(1):32-8. doi: 10.1016/j.neuroimage.2010.11.073. Epub 2010 Nov 30.

18.

Brain aging in the oldest-old.

von Gunten A, Ebbing K, Imhof A, Giannakopoulos P, Kövari E.

Curr Gerontol Geriatr Res. 2010. pii: 358531. doi: 10.1155/2010/358531. Epub 2010 Jul 25.

19.

The impact of vascular burden on late-life depression.

Santos M, Kövari E, Hof PR, Gold G, Bouras C, Giannakopoulos P.

Brain Res Rev. 2009 Dec 11;62(1):19-32. doi: 10.1016/j.brainresrev.2009.08.003. Epub 2009 Sep 8. Review.

20.

Mitochondrial accumulation of APP and Abeta: significance for Alzheimer disease pathogenesis.

Pavlov PF, Hansson Petersen C, Glaser E, Ankarcrona M.

J Cell Mol Med. 2009 Oct;13(10):4137-45. doi: 10.1111/j.1582-4934.2009.00892.x. Epub 2009 Sep 1. Review.

Supplemental Content

Support Center